PulmoVera Team Advances to the Final of TEKNOFEST 2025 3T in Oncology Competition

Our PulmoVera team has qualified for the final round of the TEKNOFEST 2025 3T in Oncology Competition with its project titled “The Anticancer Effect of Using Aloe vera in Combination with Antibiotics to Which Bacteria Involved in Lung Cancer Infections Have Developed Resistance.”

Through this innovative project, we aim to make a meaningful contribution to healthcare technologies by combining alternative approaches to address both antibiotic resistance and lung cancer treatment.

We remain committed to advancing transformative solutions in healthcare, inspiring hope through scientific research, and developing innovative approaches to complex medical challenges.

We sincerely congratulate all our team members who contributed to this remarkable achievement and wish them continued success in the final stage of the competition.